Skip to main content

Day after day, we work hard to reduce our environmental impact while contributing to a healthier planet.

At Centrient Pharmaceuticals, environmental sustainability is central to how we operate and grow. As part of our ESG Ambition 2021 – 2030, we are committed to reducing our environmental footprint while setting new standards for responsible manufacturing across the pharmaceutical industry. 

As the world faces mounting ecological challenges—from climate change to antimicrobial resistance—our industry must evolve beyond compliance and embrace leadership. 

Sustainability in pharmaceutical manufacturing means rethinking how we source, produce, and distribute medicines. It means designing processes that protect ecosystems, reduce emissions, and safeguard the efficacy of life-saving treatments. It means holding ourselves—and our partners—to higher standards. 

Across regions, governments and health systems are embedding environmental criteria into procurement, regulation, and public policy. This shift reflects a broader societal expectation: that companies contribute to a healthier planet while delivering healthcare solutions. 

Centrient is committed to playing a role in this transformation. Through our ESG strategy, we aim to set the benchmark for responsible manufacturing, inspire progress across our value chain, and help shape a future where environmental and human health go hand in hand. 

Together, we can build a more sustainable pharmaceutical industry—one that delivers impact beyond the pill.